These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3769161)

  • 1. Iodine 123-phenylpentadecanoic acid myocardial scintigraphy: usefulness in the identification of myocardial ischemia.
    Kennedy PL; Corbett JR; Kulkarni PV; Wolfe CL; Jansen DE; Hansen CL; Buja LM; Parkey RW; Willerson JT
    Circulation; 1986 Nov; 74(5):1007-15. PubMed ID: 3769161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodine-123 phenylpentadecanoic acid and single photon emission computed tomography in identifying left ventricular regional metabolic abnormalities in patients with coronary heart disease: comparison with thallium-201 myocardial tomography.
    Hansen CL; Corbett JR; Pippin JJ; Jansen DE; Kulkarni PV; Ugolini V; Henderson E; Akers M; Buja LM; Parkey RW
    J Am Coll Cardiol; 1988 Jul; 12(1):78-87. PubMed ID: 3259960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine-123 phenylpentadecanoic acid myocardial scintigraphy in patients with left ventricular hypertrophy: alterations in left ventricular distribution and utilization.
    Wolfe CL; Kennedy PL; Kulkarni PV; Jansen DE; Gabliani GI; Corbett JR
    Am Heart J; 1990 Jun; 119(6):1338-47. PubMed ID: 2141221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial scintigraphy with iodine-123 phenylpentadecanoic acid and thallium-201 in patients with coronary artery disease: a comparative dual-isotope study.
    Zimmermann R; Rauch B; Kapp M; Bubeck B; Neumann FJ; Seitz F; Stokstad P; Mall G; Tillmanns H; Kübler W
    Eur J Nucl Med; 1992; 19(11):946-54. PubMed ID: 1425781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodophenylpentadecanoic acid-myocardial blood flow relationship during maximal exercise with coronary occlusion.
    Caldwell JH; Martin GV; Link JM; Krohn KA; Bassingthwaighte JB
    J Nucl Med; 1990 Jan; 31(1):99-105. PubMed ID: 2295946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myocardial scintigraphy with iodine 123-labeled fatty acids].
    Dudczak R
    Wien Klin Wochenschr Suppl; 1983; 143():3-35. PubMed ID: 6228070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reduced myocardial fatty acid utilization in coronary heart disease following symptom limited ergometric stress. Detection of pathologic metabolic patterns using iodine-123-phenylpentadecanoic acid and sequential SPECT].
    Reske SN; Nitsch J; von der Lohe E; Simon HJ; Bardos P; Büll U
    Z Kardiol; 1989 Apr; 78(4):262-70. PubMed ID: 2786661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting and nonfasting iodine-123-idophenylpentadecanoic acid myocardial SPECT imaging in coronary artery disease.
    Heller GV; Iskandrian AE; Orlandi C; Ahlberg AW; Heo J; Mann A; White MP; Gagnon A; Taillefer R
    J Nucl Med; 1998 Dec; 39(12):2019-22. PubMed ID: 9867134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 123I-IPPA SPECT for the prediction of enhanced left ventricular function after coronary bypass graft surgery. Multicenter IPPA Viability Trial Investigators. 123I-iodophenylpentadecanoic acid.
    Verani MS; Taillefer R; Iskandrian AE; Mahmarian JJ; He ZX; Orlandi C
    J Nucl Med; 2000 Aug; 41(8):1299-307. PubMed ID: 10945518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of gallopamil on iodine-123-phenyl-pentadecanoic acid and thallium 201 uptake in patients with coronary heart disease].
    Tillmanns H; Zimmermann R; Kapp M; Rauch B; Neumann FJ; Schlumpp K; Bubeck B; Georgi P; Kübler W
    Z Kardiol; 1989; 78 Suppl 5():77-82. PubMed ID: 2698567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of improvement in left ventricular function with iodine-123-IPPA after coronary revascularization.
    Hansen CL; Heo J; Oliner C; Van Decker W; Iskandrian AS
    J Nucl Med; 1995 Nov; 36(11):1987-93. PubMed ID: 7472586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of 123I-labeled p-phenylpentadecanoic acid (p-IPPA) for myocardial scintigraphy.
    Dudczak R; Schmoliner R; Kletter K; Frischauf H; Angelberger P
    J Nucl Med Allied Sci; 1983; 27(4):267-79. PubMed ID: 6674428
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic value of 123I-phenylpentadecanoic acid (IPPA) metabolic and thallium 201 perfusion imaging in stable coronary artery disease.
    Walamies M; Turjanmaa V; Koskinen M; Uusitalo A
    Eur Heart J; 1993 Aug; 14(8):1079-87. PubMed ID: 8404938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of myocardial viability using 123I-labeled iodophenylpentadecanoic acid at sustained low flow or after acute infarction and reperfusion.
    Yang JY; Ruiz M; Calnon DA; Watson DD; Beller GA; Glover DK
    J Nucl Med; 1999 May; 40(5):821-8. PubMed ID: 10319757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary report of an ongoing phase I/II dose range, safety and efficacy study of iodine-123-phenylpentadecanoic acid for the identification of viable myocardium.
    Hansen CL
    J Nucl Med; 1994 Apr; 35(4 Suppl):38S-42S. PubMed ID: 8151411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal myocardial fatty acid metabolism in dilated cardiomyopathy detected by iodine-123 phenylpentadecanoic acid and tomographic imaging.
    Ugolini V; Hansen CL; Kulkarni PV; Jansen DE; Akers MS; Corbett JR
    Am J Cardiol; 1988 Nov; 62(13):923-8. PubMed ID: 3263035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of 15-(123I)-p-iodophenyl pentadecanoic acid (IPPA) in assessing myocardial metabolism in a model of reversible global ischemia.
    Hudon MP; Lyster DM; Jamieson EW; Qayumi KA; Kiess MC; Rosado LJ; Autor AP; Sartori C; Dougan H; van den Broek J
    Eur J Nucl Med; 1988; 14(12):594-9. PubMed ID: 3243307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhomogeneous exercise uptake and accelerated washout of a radioiodinated fatty acid analogue in syndrome X. A SPECT study of the left ventricle.
    Walamies M; Koskinen M; Uusitalo A; Niemelä K
    Int J Card Imaging; 1994 Jun; 10(2):123-9. PubMed ID: 7963750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viability after myocardial infarction: can it be assessed within five minutes by low-dose dynamic iodine-123-iodophenylpentadecanoic acid imaging with a multicrystal gamma camera?
    Murray GL; Schad N; Bush AJ
    Angiology; 1997 Apr; 48(4):309-19. PubMed ID: 9112879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic cardiac imaging in severe coronary disease: assessment of viability with iodine-123-iodophenylpentadecanoic acid and multicrystal gamma camera, and correlation with biopsy.
    Murray G; Schad N; Ladd W; Allie D; vander Zwagg R; Avet P; Rockett J
    J Nucl Med; 1992 Jul; 33(7):1269-77. PubMed ID: 1613564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.